ARCHIVES

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

Diet/Cancer Product ad Seminar Consensus: It’s Okay When Limited To Categories Of Food

November 7, 1986

ONS Adopts Scope Of Oncology Nursing Practice

November 23, 1984

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987